Evidence map›Paper›PMID 32419720›Full record

ArticleEarly human development2020

Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates.

John T Manning, Bernhard Fink

Abstract read
In one paragraph

Article in Early human development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Testosterone and Covid-19: An update.Reviews in medical virology · 2023
    Review
  3. A further analysis of Manning and Fink (2020).Early human development · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

John T ManningApplied Sports, Technology, Exercise, and Medicine (A-STEM), Swansea University, Swansea, United Kingdom.
Bernhard FinkBiosocial Science Information, Biedermannsdorf, Austria. Electronic address: bfink@gwdg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe reported national case fatality rates (CFRs) for coronavirus disease 2019 (COVID-19) shows a sex bias with males > females. The relative lengths of the index (2D) and ring (4D) fingers (digit ratio; 2D:4D) is a sexually dimorphic (males < females) proxy of fetal sex steroids (low 2D:4D indicates high prenatal testosterone/low prenatal estrogen).

aimTo examine sex-specific relationships of 2D:4D per nation with national values of COVID-19 CFRs. STUDY

designCOVID-19 CFRs and the percent of male deaths were related to mean national (self-reported) 2D:4D by sex and hand from a large online survey (the BBC Internet Study). SUBJECTS: 103,482 men and 83,366 women. OUTCOME MEASURES: Relationships of mean national 2D:4D with CFRs from 41 countries and with national male death rates from 16 countries.

resultsMale right and left hand 2D:4D showed positive relationships with CFR. These relationships remained significant after removing the influence of female 2D:4D. A positive association of male right and left 2D:4D was detected with the percentage of male deaths.

conclusionsAt the national level, high mean 2D:4D (indicating low prenatal testosterone/high prenatal estrogen) is associated with high CFRs and percent male mortality. At the individual level, high 2D:4D may be a risk factor for severity of COVID-19 in males. We speculate that male 2D:4D is a negative correlate for expression of the SARS-CoV2 receptor (ACE2).

Indexed as

AdultCoronavirus InfectionsCOVID-19EthnicityFemaleFingersHumansMalePandemicsPneumonia, ViralSex FactorsACE2Case fatality rateCoronavirusCOVID-19Digit ratioTestosterone

Identifiers

PMID32419720
PMCPMC7224643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.